• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Dialytic treatment in patients with renal insufficiency and heart failure refractory to combined drug therapy].

作者信息

Iorio L, Violi F, Simonelli R, Nacca R G, Mantella D, Caliendo A

机构信息

Unita' Operativa di Nefrologia e Dialisi, Centro di Riferimento Regionale, Ospedale G. De Bosis, Cassino (FR).

出版信息

G Ital Nefrol. 2005 Jul-Aug;22(4):365-71.

PMID:16267797
Abstract

The incidence and prevalence of heart failure are continuously on the increase. Pharmacological therapy is not sufficient in the advanced stages of the illness to control the signs and symptoms, especially when stressing factors intervene and complicate the illness course. Dialytic treatments are always indicated more than necessary in the severe forms of heart failure, but the optimal treatment has not yet been established. In our division, 24 patients with heart failure (III-IV NYHA) and renal failure (III-IV NKF-DOQI) were treated with low flux bicarbonate dialysis, variable dialysate and limited ultra-filtration. Arrhythmia, pericarditis, ischemic cardiopathy and hyponatremia were the stressing factors that determined acute heart failure. Fifteen patients presented with diastolic failure, whereas nine patients had systolic heart failure. The first group of patients had higher arterial pressure, better ejection fraction and better prognosis regarding renal function and survival rate. The results obtained with this treatment in prevalently diastolic heart failure are satisfactory in terms of survival, as well as in renal function recovery, whereas they are not adequate in systolic failure where other approaches are being studied. Therefore, we believe that the therapeutic choice must always be determined in relation to the type of heart failure.

摘要

相似文献

1
[Dialytic treatment in patients with renal insufficiency and heart failure refractory to combined drug therapy].
G Ital Nefrol. 2005 Jul-Aug;22(4):365-71.
2
Temporary dialysis treatments for heart failure in chronic kidney disease.慢性肾脏病心衰的临时透析治疗
Semin Nephrol. 2005 Nov;25(6):408-12. doi: 10.1016/j.semnephrol.2005.05.011.
3
[Long-term sustained low efficiency dialysis in eight patients with class IV NYHA heart failure resistant to high-dose diuretic treatment].
G Ital Nefrol. 2009 Jul-Aug;26 Suppl 46:50-2.
4
Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.缺血性或非缺血性心肌病所致收缩期左心室功能障碍及轻度心力衰竭症状患者的心脏再同步治疗
Am J Cardiol. 2006 Jul 15;98(2):230-5. doi: 10.1016/j.amjcard.2006.01.080. Epub 2006 May 19.
5
Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).心脏再同步治疗对II级与III级及IV级心力衰竭患者的疗效比较(来自意大利InSync/InSync ICD注册研究)
Am J Cardiol. 2007 Sep 15;100(6):1007-12. doi: 10.1016/j.amjcard.2007.04.043. Epub 2007 Jul 5.
6
Decompensated heart failure in the setting of kidney dysfunction: a community-wide perspective.肾功能不全背景下的失代偿性心力衰竭:基于社区层面的视角
Nephron Clin Pract. 2007;107(4):c147-55. doi: 10.1159/000110035. Epub 2007 Oct 22.
7
Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.影响选择不接受透析的晚期慢性肾病患者生存的因素。
Ren Fail. 2007;29(6):653-9. doi: 10.1080/08860220701459634.
8
Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.晚期依赖血管活性药物的IV级心力衰竭患者的心脏再同步治疗
Am J Cardiol. 2007 Jul 1;100(1):90-3. doi: 10.1016/j.amjcard.2007.02.058. Epub 2007 May 15.
9
Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?心脏再同步治疗能否改善终末期心力衰竭患者的生存率和生活质量?
Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1141-6. doi: 10.1510/icvts.2008.183707. Epub 2008 Jun 9.
10
Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.心脏再同步治疗对QRS波增宽的收缩性心力衰竭患者运动能力、功能容量及生活质量的影响:COMPANION试验子研究
J Card Fail. 2008 Feb;14(1):9-18. doi: 10.1016/j.cardfail.2007.08.003.